![Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023 - Miami Scientific Italian Community Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023 - Miami Scientific Italian Community](https://i0.wp.com/www.miamisic.org/site/wp-content/uploads/2023/02/Italo-Linfante-Image.jpg.png?fit=600%2C600&ssl=1)
Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023 - Miami Scientific Italian Community
![ProLong 30 Capsule – Musani Pharma – Nutraceuticals Manufacturer & RX Products Exporter In Karachi – Pakistan ProLong 30 Capsule – Musani Pharma – Nutraceuticals Manufacturer & RX Products Exporter In Karachi – Pakistan](https://musanipharma.com/wp-content/uploads/2020/09/p23.jpg)
ProLong 30 Capsule – Musani Pharma – Nutraceuticals Manufacturer & RX Products Exporter In Karachi – Pakistan
![Prolong Pharmaceuticals® | Transformative Medicine through Innovative Design with Proven Technology™ Prolong Pharmaceuticals® | Transformative Medicine through Innovative Design with Proven Technology™](http://prolongpharma.com/wp-content/uploads/2021/04/Prolong-Logo-TM-White.png)